Abstract
Ten men, 5 with ischemic heart disease and 5 healthy volunteers, were administered 20-mg Peritrate tablets containing C14-labeled pentaerythritol tetranitrate and were restricted to a clinical research unit for the collection of blood, urine and feces. The control and coronary groups exhibited no significant difference in their absorption, excretion and biotransformation of the drug. Virtually all [94.5 ± 1.5% (S.E.)] of the radioactivity was recovered from 9 subjects; the other subject was unable to provide complete fecal excretion because of an impaction. For the 10 men, the mean urinary excretion was 53.1 ± 3.4% in 24 hours and 60.3 ± 3.6% in 48 hours, and the mean fecal excretion was 31.5 ± 4.8% in 72 hours. Radioactivity was found in the blood within 15 minutes after dosing. Peak blood radioactivity was sustained over the period from 4 to 8 hours after dosing and represented approximately 5.6% of the radioactivity administered. The blood level of radioactivity declined slowly to about 40% of the maximum at 24 hours and to 10% at 48 hours. The blood, urine and feces collections were assayed for pentaerythritol tetranitrate and its de-esterified metabolites by thin-layer chromatography and radioscanning. pentaerythritol tetranitrate was found consistently in the feces, rarely in the urine, but not in the blood. Pentaerythritol trinitrate was found only in two fecal specimens. Significant levels of pentaerythritol dinitrate were present in the blood from 30 minutes to 4 hours after drug administration, and small quantities were detected in occasional urine and feces collections. The principal drug metabolites were pentaerythritol mononitrate and pentaerythritol.
Footnotes
- Received April 21, 1969.
- Accepted June 10, 1970.
- © 1970, by The Williams & Wilkins Company
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|